CLAIM #12001 · Bristol-Myers Squibb Company (BMY) · 2024Q3 earnings call · Oct 31, 2024 · due Jun 30, 2026
“We are on track to pay down our target of $10 billion of debt by the first half of 2026.”
Chris Boerner · CEO
PENDING
graded after results covering Jun 30, 2026 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q3 earnings call.